de la Cruz-Moreno Mariangeles Pérez, Montejo Consuelo, Aguilar-Ros Antonio, Dewe Walthère, Beck Benoît, Stappaerts Jef, Tack Jan, Augustijns Patrick
KineStat Pharma, Carretera del Plantío 100, 2°B, Madrid, Spain.
Universidad CEU San Pablo, Madrid, Spain.
Int J Pharm. 2017 Aug 7;528(1-2):471-484. doi: 10.1016/j.ijpharm.2017.05.072. Epub 2017 Jun 4.
One of the main factors defining intestinal drug absorption is the solubility of the compound in the gastrointestinal environment. This study reports the solubility of a series of 27 commonly used acidic, neutral and basic drugs in human intestinal fluid samples collected from the duodenum or jejunum of healthy volunteers under fasted state conditions. The interindividual variability as well as the impact of factors such as pH, sampling site and bile salts on the solubility in human intestinal fluids was investigated. The solubility measurements were evaluated using a statistical experimental design. Variability in solubility across volunteers and sampling sites was highly compound-specific and appeared to be substantial for weak acids and bases and for lipophilic drugs. Both pH of the samples and the abundance of amphiphilic components were responsible for the variability observed in the solubility values obtained. The results confirm strong interindividual differences in intraluminal solubility, especially for compounds with high lipophilicity and/or compounds with a pKa value within the physiological pH range. It is important to recognize this variability in intestinal drug solubility as it may considerably influence the therapeutic outcome among patients.
决定肠道药物吸收的主要因素之一是化合物在胃肠道环境中的溶解度。本研究报告了一系列27种常用酸性、中性和碱性药物在空腹状态下从健康志愿者十二指肠或空肠采集的人体肠液样本中的溶解度。研究了个体间变异性以及pH值、采样部位和胆汁盐等因素对人体肠液中溶解度的影响。溶解度测量采用统计实验设计进行评估。志愿者和采样部位之间溶解度的变异性具有高度的化合物特异性,对于弱酸、弱碱和亲脂性药物而言似乎很大。样本的pH值和两亲性成分的丰度都是所获得溶解度值中观察到的变异性的原因。结果证实管腔内溶解度存在显著的个体间差异,特别是对于高亲脂性化合物和/或pKa值在生理pH范围内的化合物。认识到肠道药物溶解度的这种变异性很重要,因为它可能会显著影响患者的治疗效果。